Room: Mediterranean Ballroom

Anchor Molecular, Inc.

1. Characterization of DNA-Depleted Plasma and Evaluation of Plasma-Based Quality Controls for Specificity and Sensitivity of cfDNA Extraction; Presented by Yabin L.

Chung Shan Medical University

2. The Role of PERP-428 SNP in ROS Protection and Risk of Lung Cancer; Presented by Chen-Yi L.

Commonwealth Scientific and Industrial Research Organisation (CSIRO)

3. A PCR Assay to Specifically Detect cfDNA from Dying Neurons and Glia; Presented by Jason R.

Genome Institute of Singapore

4. Developing Companion Diagnostic Assay to Determine the Effectiveness of Adoptive T Cell Therapy for Hepatitis B Liver Cancer Patients; Presented by Say Li K.


5. Roll-to-Roll (R2R) Nano/Micro-Imprinting to Enable Fully Foil Based PoC Tests with High Sensitivity and Low Production Costs; Presented by Max S.

Hamilton Bonaduz AG

6. High Throughput Automation of Single Cell Copy Number Alteration Profiling, Using the Ampli1™ LowPass Library Prep Workflow for Illumina® Sequencing; Presented by Federico S.

Health Research Institute of Santiago de Compostela (IDIS)

7. Evaluating Metastatic Potential of Breast Cancer CTC-Clusters in the Zebrafish Model; Presented by Roberto C.

Invitek Molecular GmbH

8. Comparison of cfDNA Quality Depending on Extraction Method for NGS Analysis; Presented by Andrea O.

Kanazawa University Hospital

9. Intra-Tumoral Gene Profile of Mutations Detected by Liquid Biopsy in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations; Presented by Hideharu K.

Korea Testing Certification

10. Asian Regulations for IVD Approval and the Market; Presented by Mi Suk N.

National Health Research Institutes

11. Application of CHROMagar and MALDI-TOF Mass Spectrometry for Isolation and Identification of Commensal Oral Yeasts in Nursing Elders; Presented by Hsiu-Jung L.

National Institute for Biological Standards and Control (NIBSC)

12. Is It Time for an International Genomic Reference Panel for MSI and TMB?; Presented by Leandro L.

National Institute for Biological Standards and Control (NIBSC)

13. Towards Internationally Agreed Units for Cancer Genomic Measurements Worldwide: The Role of WHO International Standards; Presented by Angela S.

Novartis Institutes for BioMedical Research

14. Reducing Patient Burden in Clinical Trials: Huge Opportunities from Smart Sampling and Point-of-Care Testing Devices!; Presented by Julie M.

University Hospital of Zurich

15. Novel Urine Biomarkers for the Screening of Prostate Cancer; Presented by Blaz P.

University of Edinburgh

16. Detection of Circulating Cell Free DNA in Advanced Renal Cancer Patients Using Renal Cancer Specific DNA Mutations and Methylation Changes; Presented by Martyna A.

University of Freiburg

17. Sensitive Detection of Pseudomonas aeruginosa Based on Recombinase Polymerase Amplification Combined with an Immunological Assay; Presented by Anna B.

University of Leicester

18. Exploiting Bacteriophages as a Novel Diagnosis for Bacterial Infections: A Case Study of Lyme Disease and Its Co-Infection with Bartonellosis and Relapsing Fever; Presented by Jinyu S.

Wonkwang University

19. POCT for Highly Pathogenic Avian Influenza H5 Subtype; Presented by Hyun P.

Wonkwang University

20. On-Site Monitoring of Respiratory Virus by Immunochromatographic Strip Test (FICT); Presented by Seon-Ju Y.

Wonwkang University

21. Isolation of Avian Influenza Virus in Wild Birds of Korea, China, Mongolia and Hong Kong; Presented by Mudsser A.

Wonwkang University

22. Clinical Evaluation of Rapid Fluorescent Diagnostic Immunochromatographic Test for Influenza A Virus (H1N1); Presented by Bao Duong T.